• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4676890)   Today's Articles (2661)
For: Leng B, Shen C, Gao T, Zhao K, Zhao X, Guo Y, Wu J, Yang J, Fang W, Zhang J, Zhang Y, Sun C, Duan L, Huang J, Qi Y, Yan G. Incidence, characteristics and risk factors of hypofibrinogenemia associated with tigecycline: A multicenter retrospective study in China. Front Pharmacol 2022;13:943674. [PMID: 36304151 PMCID: PMC9592897 DOI: 10.3389/fphar.2022.943674] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2022] [Accepted: 09/23/2022] [Indexed: 11/13/2022]  Open
Number Cited by Other Article(s)
1
Wen X, Cai L, Gao A, Fu A, Guo D, Zhu M. Pharmacovigilance analysis of drug-induced hypofibrinogenemia using the FDA Adverse Event Reporting System. Int J Clin Pharm 2025:10.1007/s11096-025-01867-6. [PMID: 39888490 DOI: 10.1007/s11096-025-01867-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2024] [Accepted: 01/04/2025] [Indexed: 02/01/2025]
2
Cai L, Wen X, Qiu Z, Fu A, Guo D, Zhu M. Characteristics, risk factors and a risk prediction model of tocilizumab-induced hypofibrinogenemia: a retrospective real-world study of inpatients. BMC Pharmacol Toxicol 2025;26:5. [PMID: 39789607 PMCID: PMC11721054 DOI: 10.1186/s40360-024-00827-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2024] [Accepted: 12/17/2024] [Indexed: 01/12/2025]  Open
3
Li M, He J, Dong G, Hu L, Shao H. Serum concentration threshold and risk factors of tigecycline-induced hypofibrinogenaemia in critically ill patients. J Antimicrob Chemother 2025;80:200-208. [PMID: 39508368 DOI: 10.1093/jac/dkae396] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2024] [Accepted: 10/18/2024] [Indexed: 11/15/2024]  Open
4
Sun H, Meng X, Shao X, Duan L, Fan K. Impact of Tigecycline on Coagulation in Severe Infections and Effect of Vitamin K1 Intervention: A Retrospective Single-Center Analysis. Med Sci Monit 2024;30:e944778. [PMID: 39488729 PMCID: PMC11542504 DOI: 10.12659/msm.944778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2024] [Accepted: 08/29/2024] [Indexed: 11/04/2024]  Open
5
Ma C, Ren X, Pang N, Liu Y, Chen M, Zhang X, Liu Y, Huang L. Incidence, characteristics, and risk factors of hypofibrinogenemia induced by generic tigecycline: a retrospective study. NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY 2024:10.1007/s00210-024-03419-7. [PMID: 39254879 DOI: 10.1007/s00210-024-03419-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/04/2024] [Accepted: 08/29/2024] [Indexed: 09/11/2024]
6
Zhang X, Pan J, Zhang X, Yang Q, Li Z, Liu F. Safety profiles of tetracycline-class drugs: a pharmacovigilance analysis of the FAERS database. Expert Opin Drug Saf 2024:1-10. [PMID: 39158402 DOI: 10.1080/14740338.2024.2393276] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2024] [Revised: 07/18/2024] [Accepted: 07/29/2024] [Indexed: 08/20/2024]
7
Firat O, Kara E, Malkan ÜY, Demirkan K, Inkaya AÇ. Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study. Thromb Res 2024;236:155-160. [PMID: 38452447 DOI: 10.1016/j.thromres.2024.03.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2023] [Revised: 02/27/2024] [Accepted: 03/04/2024] [Indexed: 03/09/2024]
8
Guo J, Wang S, Zhou M, Cao J, Cai X, Zhang W, Zhao W, Zhang F, Tian S, Qian X, Zhang J, Li B. Nomogram for the prediction of tigecycline-induced hypofibrinogenaemia in a Chinese population. Int J Antimicrob Agents 2024;63:107062. [PMID: 38104947 DOI: 10.1016/j.ijantimicag.2023.107062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2023] [Revised: 12/02/2023] [Accepted: 12/08/2023] [Indexed: 12/19/2023]
9
Zhang L, Cai X, Peng F, Tian S, Wu X, Li Y, Guo J. Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies. Front Pharmacol 2023;14:1182644. [PMID: 37351509 PMCID: PMC10282135 DOI: 10.3389/fphar.2023.1182644] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2023] [Accepted: 05/30/2023] [Indexed: 06/24/2023]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Excel